Janssen R&D Unveils Three New Research Platforms
This article was originally published in The Pink Sheet Daily
Executive Summary
With an emphasis on early disease intervention, J&J’s Janssen R&D unit launched three new research platforms – disease prevention, disease interception and the microbiome.